The Effect of Distractive Auditory Stimuli (Music) on Dyspnea and Anxiety During Exercise in Adults With Chronic Respiratory Diseases

Not Applicable

Completed

• Conditions: Chronic Obstructive Pulmonary Disease
• Interventions: Procedure: Distractive Auditory Stimuli; Procedure: No Distractive Auditory Stimuli

• Registration Number: NCT02955108
• Lead Sponsor: NYU Langone Health

Brief Summary

The objective of this study is to look at the effects of distractive auditory stimuli (DAS) on reducing dyspnea intensity and related anxiety and increasing exercise tolerance. Investigators hope that compared to a no-music control condition, that under a music condition participants with COPD will (a) demonstrate increased self-paced walk distance and enjoyment; (b) have less dyspnea intensity, (c) experience less dyspnea anxiety; (d) have less fatigue and state anxiety; and (e) higher maximum heart rate. The upbeat music with a tempo of 90 - 100 bpm (an average-to-moderate walking tempo) is expected to have distractive and performance enhancing effects in order to increase tolerance to dyspnea and exercise. The long-term goal of this study is to increase physical activity in adults with COPD and RLD by promoting dyspnea and fatigue management through use of distractive auditory stimuli in the form of music.

Detailed Description

This randomized clinical trial will use a cross-over design. The research will include two within-subject factors, music versus no music and time. Each subject will be randomized a single time to receive either music first then no music, or alternatively, no music first then music during two walk tests.

Study Timeline

• Study First Submitted: 2016-11-02
• Study First Submitted QC: 2016-11-02
• Study First Posted: 2016-11-04
• Study Start: 2017-10-27
• Primary Completion: 2018-11-14
• Study Completion: 2018-11-14
• Status Verified: 2021-07
• Last Update Submitted: 2021-07-30
• Last Update Posted: 2021-08-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

• English speaking

• aged 40 years or older, with physician-diagnosed COPD

• a flow volume loop with a FEV1/FVC of < 0.70 in the past 12 months

  • medically cleared to participate in NYULMC's pulmonary rehabilitation program.

Read More

Exclusion Criteria

• Inability to exercise due to musculoskeletalor neurological dysfunction
• Inability to walk independently (unaided)
• deafness or severe hearing impairment requiring hearing aids
• mMRC score = 0 ("I only get breathlessness with strenuous exercise").

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
music first then no music	No Distractive Auditory Stimuli	-
no music first then music	Distractive Auditory Stimuli	-
music first then no music	Distractive Auditory Stimuli	-
no music first then music	No Distractive Auditory Stimuli	-

Primary Outcome Measures

Name	Time	Method
Dyspnea Intensity (DI)	60 Minutes	Borg Breathlessness Scale. The Borg dyspnea scale is a single-item rating scale, ranging between 0, "nothing at all", and 10, "very, very severe (maximal)". Patients will be asked to rate their level of dyspnea during the walk test using the 10-point Borg scale after the 6MWT.64 Validity of the Borg scale for measuring dyspnea intensity has been shown.65

Trial Locations

Locations (1)

New York University School of Medicine; 🇺🇸 New York, New York, United States